Affiliation:
1. Stavropol State Medical University, Stavropol
2. City Polyclinic № 2, Stavropol
3. Stavropol Research anti Plague Institute of Rospotrebnadzor, Stavropol
Abstract
Brucellosis is characterized by nonspecific clinical manifestations, the possibility of subclinical flow, the development of relapses and chronic course. Currently, there are nolaboratory criteria to assess the activity of inflammation in brucellosis, the effectiveness of the therapy, predict the outcome of the disease and the risks of recurrence. Available in clinical practice, laboratory tests to assess inflammation, in particular, erythrocyte sedimentation rate, C-reactive protein, leukocyte level, with brucellosis infection are almost not informative. An important role in the development of the cellular immune response against brucella is played by interferon-γ, lipopolysaccharide-binding protein and neopterin. The aim of the study was to determine the level of lipopolysaccharide-binding protein, neopterin and interferon-γ,in the serum of patients with acute form of brucellosis beforeand after antibacterial treatment. When studying the blood of patients with acute brucellosis before and after therapy, the indices of neopterin, lipopolysaccharide-binding protein and interferon-γ were significantly higher than normalvalues. The obtained results testify to the persisting active inflammation and the formation of a chronic brucellosis. Determination of the level of lipopolysaccharide-binding protein, neopterin and interferon-γ in the blood of patients withbrucellosis can be used as markers of inflammation and in monitoring the effectiveness of antibacterial therapy.
Reference27 articles.
1. Pappas G., Papadimitriou P., Akritidis N. et al. The new global map of human brucellosis // Lancet Infectious Diseases. 2006. №6. P. 91-99.
2. Overview of the epidemiological and epizootic situation of brucellosis in the Russian Federation in 2016 and the forecast for 2017 // Federal Governmental Health Agency Stavropol anti Plague Institute of Rospotrebnadzor [Internet]. URL: http://www.snipchi.ru/updoc/Obzor.pdf (cited 2018 July 16).
3. Ariza J., Bosilkovski M., Cascio A. et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLOS medicine. 2007. Volume 4, Issue 12, e317. P. 1872-1878.
4. Demirdag K., Ozden M., Kalkan A. et al. Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers // FEMS Immunology and Medical Microbiology. 2003. № 39. P. 149-153.
5. Aktug Demir N., Ural O. Serum interleukin-8 levels may predict relapse in brucellosis // Turkish Journal of Medical Sciences. 2012. № 42 (5). P. 796-801.